[225Ac]Ac-DOTATOC

N/A

Report date: 2025/11/20 16:04:03

NME

Base Information

Drug Name[225Ac]Ac-DOTATOC

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionSomatostatin receptor 2 binders

TargetsSomatostatin receptor 2

Therapy Area/IndicationsPancreatic neuroendocrine tumors (pNET)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNantes University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesNantes University Hospital

Inactive CompaniesN/A

Active IndicationsPancreatic neuroendocrine tumors (pNET)

Inactive IndicationsN/A

Other Information

ATC CodeN/A